Cardinal spins off medical technology business
Executive Summary
Cardinal Health will spin off its medical technology businesses as a separate public company, leaving Cardinal with its pharmaceutical and medical product distribution business. Cardinal CEO Kerry Clark will retire from the company after completion of the spinoff, to be succeeded by current health care supply chain services CEO George Barrett. David Schlotterbeck, CEO of clinical and medical products, will head the new company, to be headquartered in San Diego. The proposed tax-free spinoff will be done through a pro rata distribution to Cardinal shareholders and is expected to be completed in mid-2009. Cardinal discussed the potential benefits of a spinoff during its most recent quarterly earnings call (1"The Pink Sheet," Aug. 11, 2008, p. 22)
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.